Minervan lounasseminaari 16.4. / Faculty Club Biomedicum klo 11:50-13

Professori Annalisa Berzigotti
Bernin yliopisto ja Bernin yliopistollinen sairaala
Sveitsi

”Non-invasive imaging methods of the liver”

📅 Milloin? Torstaina 16. huhtikuuta
🕙 Aika: klo 11:50 – 13
📍 Missä? Faculty Club, Biomedicum 1

Novo Nordiskin edustaja Ilkka Vauhkonen pitää tilaisuuden alussa lyhyen 10 minuutin esityksen.

Tapahtumaan osallistuminen voidaan lukea hyväksi 1 tunti sisätautien, endokrinologian ja gastroenterologian erikoistumiskoulutuksesta.

Varmistaaksesi lounaasi, ilmoittaudu osoitteessa cia.olsson@minervainstitute.fi viimeistään tiistaina 7. huhtikuuta.

Bio (englanniksi):
Annalisa Berzigotti is Full Professor of Clinical Hepatology at the University of Berne and Chief of Hepatology and Co-Director of the Department of Visceral Surgery and Medicine of the Inselspital, University Hospital of Berne, Switzerland.

She earned her medical degree and completed her residency in Bologna, Italy, and further specialized in liver disease research and clinical practice at the Hepatic Hemodynamic Laboratory of the Liver Unit, Hospital Clinic, University of Barcelona, Spain.

Her primary interests include the invasive and non-invasive assessment and management of chronic liver disease and portal hypertension. She has authored/co-authored over 350 peer-reviewed publications on the clinical and translational aspects of liver disease.

She has authored/co-authored over 350 peer-reviewed publications on the clinical and translational aspects of liver disease. She has authored/co-authored over 350 peer-reviewed publications on the clinical and translational aspects of liver disease. She has authored/co-authored over 350 peer-reviewed publications on the clinical and translational aspects of liver disease.

Her work has been recognized with the Stern-Gattiker Prize (Switzerland, 2018), the Lucie Bolte Prize (Germany, 2021), and the EASL Community Award (2025). In 2025, she delivered the Jean-Pierre Benhamou Clinical State of the Art Lecture at the EASL Congress, entitled “The Promise and Pitfalls of Non-Invasive Testing.”

Tervetuloa!

27.3.2026